Sérgio Antônio Draibe

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 612 citations · Full text

Medicine, Endocrinology, Nephrology +10

Early Control of PTH and FGF23 in Normophosphatemic CKD Patients

Rodrigo Cardoso de Oliveira, Ana Cancela, Fabiana G. Graciolli et al. · Clinical Journal of the American Society of Nephrology · 2009 · 354 citations · Full text

Medicine, Endocrinology, Nephrology +16

Quality of life in patients with chronic kidney disease

Carolina Pieroni Andrade, Milton Urrutia, Sérgio Antônio Draibe et al. · Clinics · 2011 · 267 citations · Full text

Medicine, Nephrology, Dialysis +16

K/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients

Fellype Carvalho Barreto, Daniela Veit Barreto, Rosa Maria Affonso Moysés et al. · Kidney International · 2008 · 239 citations · Full text

Medicine, Endocrinology, Nephrology +13

Phosphate Binder Impact on Bone Remodeling and Coronary Calcification – Results from the BRiC Study

Daniela Veit Barreto, Fellype de Carvalho Barreto, Aluízio B. Carvalho et al. · Nephron Clinical Practice · 2008 · 172 citations

Medicine, Cardiology, Nephrology +17